Harald Nusser, a seasoned healthcare executive with global experience in health equity and social business, opened our discussion about Biopharma and Human Rights with a focus on the right to health. Additional perspectives were shared by BSRT colleagues from Hikma, Organon, Pfizer, and Roche.
